cdk4/6 inhibitors & endocrine therapy: selecting a regimen
Published 5 years ago • 38 plays • Length 6:05Download video MP4
Download video MP3
Similar videos
-
6:46
cdk4/6 inhibitors & endocrine therapy: treatment resistance
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
4:35
cdk4/6 inhibitors & endocrine therapy: adverse events
-
4:15
case 2: choosing a cdk4/6 inhibitor in er breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
1:59:33
addressing current questions and controversies in the management of metastatic breast cancer
-
4:37
case 2: cdk4/6 inhibitors in er breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
3:21
benefits and challenges of cdk4/6 inhibitors
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
3:56
hr breast cancer: risk-stratifying to cdk4/6 inhibitors
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
3:04
optimizing cdk4/6 inhibition in hr breast cancer
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial